Hexal Biotech competitive analysis

Explore patent oppositions filed by Hexal Biotech against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition Date
Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5-D]Pyrimidin DerivateASTRAZENECADec 21, 2017

Latest PTAB cases involving Hexal Biotech

Discover the latest PTAB cases involving Hexal Biotech, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hexal Biotech with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 6, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HEXAL BIOTECH1 - - -
ASTRAZENECA - 49 - 18